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ABSTRACT 
 
 
Intrinsically Disordered Proteins May Select Partners by Fold. (December 2010) 
 
Kim Lani Gonzalez 
Department of Biochemistry and Biophysics  
Texas A&M University  
 
 
Research Advisor: Dr. Sarah Bondos 
Department of Molecular and Cellular Medicine 
 
 
Intrinsically disordered proteins lack a rigid structure due to their simple amino acid 
sequence. Because of their multiple roles, disordered proteins often account for a 
majority of proteins known to be associated with various diseases. In particular, these 
unstructured proteins tend to have pivotal roles in protein-protein interactions that occur 
in cell signaling. For structured proteins, surface topology complementarities play a 
crucial role in the selection of protein interactions and stabilization of the interaction 
interface. In contrast, the mechanism through which intrinsically disordered proteins 
select binding partners still remains unresolved. To gain more knowledge of binding 
interactions of disordered proteins, we examined the binding tendencies of 
Ultrabithorax, Ubx, a Hox protein consisting of both structured and intrinsically 
disordered regions. Of the 33 known proteins bound by Ubx, 15 have only 3 of a 
possible 1200 folds, suggesting Ubx selects protein partners by topology. To determine 
whether the structured or disordered region mediate binding, and thus topological 
selection, we used a yeast two-hybrid system to evaluate the strength of interactions 
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between Ubx and its binding partner. Results indicate that the intrinsically disordered 
regions of this protein are the reason for binding its partner. This is the first 
demonstration that surface topology is an important criterion for protein interactions 
involving intrinsically disordered regions. 
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NOMENCLATURE 
 
SCOP Structural Classification of Proteins 
SD Standard Dropout 
ONPG o-nitrophenyl β-D-galactopyranoside 
Ubx Ultrabithorax 
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CHAPTER I 
INTRODUCTION 
 
The amino acid sequence is the primary structure of all proteins. Interactions between 
these amino acids, like hydrogen or disulfide bonds, give rise to a unique protein fold. 
When binding a substrate or partner protein, structured proteins are typically expected to 
abide by induced fit or the lock and key mechanism. In both of these mechanisms, the 
structure of the interacting proteins is a critical determinant of the ability to bind. The 
need for proteins to have a certain shape in order to bind a partner or substrate is not the 
only requirement; the interacting proteins must have chemical compatibility. For 
instance, if two proteins are negatively charged throughout, they will not create an 
intimate contact regardless of their structure.  
 
A complication with this rule arises when the protein lacks structure. Intrinsically 
disordered proteins lack a rigid structure due to a simple amino acid sequence, generally 
enriched in charged amino acids and depleted in hydrophobic residues (1). Intrinsically 
disordered regions often engage in protein-protein interactions, allowing a protein to 
bind to its partners with high specificity, yet can be easily reversed without many 
structural requirements (1). In graph theory parlance, “hubs” or proteins that engage in 
multiple interactions are more likely to be disordered. Little is known about the rules 
_______________ 
This thesis follows the style of Journal of Biological Chemistry. 
  2 
governing these unstructured proteins.  
 
Disordered proteins in nature 
Intrinsically disordered proteins occur in all three kingdoms, but are more prevalent in 
eukaryotes (2). Eukaryotes had 35-51% disordered proteins in its proteome in a study 
spanning 30 organisms, in comparison to bacteria having 6-33% and archaea having 9-
37% disordered proteins (3). In 2006, Haynes et al compared the amounts of intrinsically 
disordered proteins in humans, C. elegans, D. melanogaster, and S. cerevisiea and found 
that humans had the most intrinsic disorder compared to the other three eukaryotes. The 
high demand for cell signaling in these organisms may account for the increase in 
intrinsically disordered proteins (3). Indeed, disordered proteins are known to play major 
roles in regulation, transcription, and translation (4). These unstructured proteins also 
have key functions in protein-protein interactions that occur in cell signaling (5). 
Problems with the protein-protein interactions could ultimately trigger disease. 
Disordered proteins account for 79% of proteins and 66% of signaling proteins known to 
be associated with cancer (2). In addition to having association with cancer, about 57% 
of cardiovascular proteins are also intrinsically disordered (6). 
 
Because intrinsically disordered proteins participate in various vital functions in many 
organisms, it is imperative to understand their protein interaction regulations. Because 
these unstructured proteins appear in multiple diseases, rather than a single disease, this 
research is applicable to more fields of study. If we can better understand these 
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interactions, we would not only gain insight into the normal function of an organism, but 
we could also pave the way for the development of therapies or medicines for diseases 
caused by protein-protein interactions. 
 
Single protein, multiple interactions 
Little is known about the mechanism through which intrinsically disordered proteins 
select binding partners. Disordered proteins tend to be a part of biological networks, 
acting as “hubs” for protein-protein interactions (1). These signaling hubs can have 
interactions ranging from a few hundred or a few millions, and removal of hub proteins 
is frequently fatal (1). A common opinion is that the intrinsic disorder could be an 
advantage in regards to binding; the flexible unstructured region of a protein could allow 
binding to multiple partner conformations (1). Intrinsic disorder permits these hub 
proteins to partake in a plethora of interactions; they do not need to follow the induced 
fit or lock and key mechanisms (1). But what is allowing an intrinsically disordered 
protein to recognize its partner, and how can it bind specifically to many different 
partners?  
 
Tompa and Fuxreiter proposed that the proteins might be disordered when unbound, but 
may gain some structure upon binding its partners. They proposed the flexibility could 
be due to three different models: the clamp model, the flanking model, or the random 
model. The clamp model looks at proteins that form structured ends separated by a loop 
of disorder when binding to another protein (7). The flanking model suggests the 
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opposite; the structure arises in the middle of the protein when bound, but has tails of 
intrinsic disorder on either end (7). The random model, the most extreme of the three, 
insinuates that the regions of disorder stay unstructured when binding (7). These models 
focus on the importance of structure, a major aspect for protein function, with regards to 
binding. We are also interested in how this disorder contributes to binding and chose to 
examine protein-protein interactions of an intrinsically disordered protein. 
 
Ultrabithorax is a disordered protein 
Ultrabithorax, Ubx, is an intrinsically disordered Hox protein consisting of both 
structured and intrinsically disordered regions (8). There are four regions of disorder in 
Ubx, but the first two being less than 20 amino acids in length, would not be a 
significant contributor to binding interactions (8). For our purposes, the term “disordered 
region” will refer to a segment having more than twenty amino acids.  
 
Previous research showed that Ubx interacts with 29 partner proteins. Within this group 
the partners shared only five folds. Given there are 1182 known protein folds found in 
the Structural Classification of Proteins, SCOP, Ubx appears to be selecting partners by 
topology. The structure of the Ubx sequence is mainly intrinsically disordered in amino 
acids 1-216 and in the microexon region N-terminal to the homeodomain (8). Ubx also 
has structured regions, mainly the homeodomain, that may contribute to partner selection 
(8). If the disordered regions determined partner selection, we could use Ubx to ascertain 
the rules for the interactions by unstructured proteins. Preliminary results suggest that 
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the binding partner is selected by the disorder. Since little is known about unstructured 
protein binding properties, we will also determine whether intrinsically disordered 
proteins generally select binding partners by fold.  
 
We have several reasons to investigate this subject. First, we would like to test the role 
of the intrinsic disorder portion of Ubx in protein-protein interactions. If the intrinsically 
disordered regions are required for binding, we could confirm that Ubx selects its 
binding partner by shape. Second, if this can be proven, the next test would be to 
determine if other intrinsically disordered proteins select binding partners by fold as 
well. Third, by inspecting known interactions, we must determine if the selection is 
seeking grooves or a canyon-like shape, which increases contact or interactions with the 
binding partners.  
 
In this work we use yeast two hybrid to investigate our hypothesis. LexA is a DNA 
binding domain that we fuse to Ubx, whereas the binding partner has a B42 activating 
domain attached. If the binding partner and Ubx interact, then the B42 activating domain 
and LexA DNA binding domain are in a single protein complex that can activate the 
transcription of genes downstream of LexA DNA binding sites. However, since the Ubx 
protein already contains an activation domain, we have to alter one of two things to 
prevent self-activation: sever the N-term to the 216th amino acid or utilize a proline 
mutant. The central question is whether or not the binding partners need the intrinsically 
disordered regions to bind. Therefore, we also examined binding of Ubx with the 
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intrinsic disorder regions- the N-term to the 216th amino acid and the microexon region 
removed. If the partner does not bind without both regions of disorder, we will test if 
either the N-term to the 216th amino acid region or the microexons can restore binding. 
β-galactosidase liquid assays will be employed in testing the protein-protein interactions 
to quantitatively compare binding to Ubx and its variants. 
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CHAPTER II 
EXPERIMENTAL PROCEDURES 
 
Yeast two-hybrid screen 
The reporter host strain is Saccharomyces cerevisiae EGY48 [MATR ura3 his3 trp1 
LexAop(x6) LEU2]; this strain also carries a wild-type LEU2 gene directed by a series 
of LexA operators. A reporter plasmid, p8op-lacZ, transformed EGY48 and carries the 
lacZ reporter gene. This gene is also controlled by LexA operators in order to ensure 
stable transformation before testing activation by introduction by plasmids. 
 
This yeast was grown and then inoculated in Glu/-Trp/-Ura liquid media overnight in a 
30°C at 225 rpm. After removing from the incubator, 500 µl of the yeast was pipetted 
into 1.5 ml Eppendorf tubes, which are labeled for the desired DNA to be transformed. 
These tubes were centrifuged for 30 seconds at 10,000 rcf. The supernatant was then 
removed and the cell pellet was washed sequentially with two different buffers. Then 
500 ng of DNA to be transformed was added to the washed cells. 10 µl of the salmon 
sperm was added next. The 10 mg/ml salmon sperm DNA was denatured in an 
Eppendorf thermomixer at 96°C and 300 rpm for six minutes. The 1.5 ml Eppendorf 
tube was then vortexed at a medium speed for 10 seconds. These tubes were then placed 
into a hot water bath for one hour at 45°C. After incubation the tubes were centrifuged 
for 20 seconds on the mini-centrifuge, and the supernatant was discarded. Then about 
120 µl of nuclease free water was added to the tube to resuspend the yeast cells using a 
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pipette. Aliquots of 40 µl of this suspension were dispensed onto three separate 
Gal/Raf/-His/-Ura/-Trp plates. These plates were then incubated for 4 to 5 days at 30°C. 
 
β-galactosidase assays  
The procedures for the β-galactosidase liquid assays were followed as outlined in the 
Clontech Yeast Protocols Handbook for liquid cultures using ONPG as a substrate. 
Overnight cultures in were prepared in liquid SD selection in test tubes. The fresh 
culture was incubated at 30°C while shaking at 230 rpm until the OD600 reading of 1ml 
of culture was between 0.5-0.8. This OD600 was recorded when the cells were ready to 
be harvested. Three 1.5 ml microcentrifuge tubes each received 1.5 ml of the harvested 
culture, and were centrifuged at 14,000 rpm for 30 seconds. The supernatant was then 
removed and the cells were resuspended in 1.5 ml of Z buffer, and centrifuged again at 
14,000 rpm for 30 seconds. Afterwards, only 300 µl of Z buffer was used to resuspend 
the cells. Three new 1.5 ml microcentrifuge tubes each received 100 µl of the cell 
suspension, and then were stored at -80°C until needed.  
 
The cells were removed from the freezer and heat shocked by submerging the tubes in 
liquid nitrogen for 45 seconds and then placing in 37°C water bath for 1 minute. This 
was repeated twice more. A blank, containing 100 µl of Z buffer, and the sample tubes 
each received 700 µl of Z buffer + β-mercaptoethanol and then 160 µl of fresh ONPG. 
The tubes were then placed in the 30°C incubator, and at this point the timer was set. 
When a yellow color developed 400 µl of stop buffer (1M Na2CO3) was added to the 
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tube, and the timer was stopped. These tubes were centrifuged for 10 minutes at 
14,000rpm and about 1 ml of supernatant was transferred to clean, disposable cuvettes. 
The spectrophotometer was calibrated at λabs=420 nm using the prepared blank, and then 
the optical density measurements for the samples at 420 nm were recorded. Afterwards, 
the β-galactosidase units were calculated using the following equation:  
β-galactosidase units = (1000 x OD420)/(t x V x OD600)  
Once all the β-galactosidase units were configured for every Ubx isoform, the data was 
then used to create the graphs seen in the results section. 
 
During the process of growing and collecting samples, there was quite a labeling 
misfortune. These cultures had to be discarded, resulting in a few different Ubx isoforms 
not having as many various partners to be tested. During the research we attempted more 
samples than reported, but some samples did not provide colonies for the assay. In order 
to report data with validity, these samples were not reported in this paper. Of course 
these tests would provide more valid data, and are in the process of being completed. 
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CHAPTER III 
RESULTS 
 
Various isoforms of Ubx were tested to determine whether intrinsically disordered 
regions mediate binding to protein partners (Fig. 1). The regions of disorder lie between 
amino acids 103-216 and in the microexons (8). The role of the first disorder region, 
between amino acids 103-216, will be probed by examining a truncation and internal 
deletion. In contrast, the role of the microexons will be tested with naturally occurring 
mRNA splicing isoforms. The full-length isoform, pLexA-UbxIbPro4, contains all three 
of the unstructured microexons: b, I, and II (9). In comparison, the isoform pLexA-
UbxIVaPro4 contains all regions except for the three microexons (9). We employed the 
pLexA-UbxIVaPro4 isoform to test the binding influences of the three microexons, 
while still maintaining the large segment of disorder at amino acids 103-216. This large 
segment of disorder at amino acids 103-216 is removed in the isoform pLexA-
UbxIb103-216. 
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FIGURE 1. Various Ubx isoforms used in yeast two-hybrid analysis. This figure shows the four 
different isoforms of Ubx. The top figure, labeled UbxIb, is the full-length protein consisting of 389 amino 
acids. The red bars across the top denote intrinsically disordered regions over 20 amino acids in UbxIb. 
The purple section represents the disordered region between amino acids 103-216. The yellow segment 
represents the “b element” microexon, and is found at amino acid 248 in the full length Ubx isoform. The 
green segment represents microexon I. The light blue represents microexon II. The orange segment of the 
protein represents the homeodomain. The dark blue represents all other amino acids within the protein. 
 
The partner used for these tests performed is CBP80, one of five Ubx partners with an 
alpha-alpha superhelix fold. All of the Ubx isoforms were fused to the pLexA binding 
domain and CBP80 has a B42 activating domain attached. If CBP80 and Ubx interact, 
then the B42 activating domain and LexA DNA binding domain form a single protein 
complex that can activate the transcription of genes downstream of LexA DNA binding 
sites. Nonetheless, the Ubx protein already contains an activation domain, therefore we 
have to remove the N-term to the 216th amino acid or utilize a proline mutant to prevent 
self-activation. Both isoforms containing “Pro4” in its name are proline mutants, and the 
other two isoforms remove the activation domain, and therefore do not require the 
proline mutation. Ubx and binding partner interactions activate the transcription of the 
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Lac-Z gene downstream of the pLexA DNA binding sites, resulting in β-galactosidase. 
The β-galactosidase liquid assays were employed to quantitatively assess the interactions 
between Ubx and its binding partner, measured in β-galactosidase units. The β-
galactosidase units are indicative of binding interactions, the larger the β-galactosidase 
units the greater the binding interactions. The relative interactions between the Ubx 
isoforms and binding partner can be seen below (Table 1 and Fig. 2). 
 
TABLE 1 
Relative interactions between Ubx isoforms and binding partner CBP80 
This table summarizes the average of the β-galactosidase liquid assays along with standard deviation for 
various binding partners among different Ubx isoforms. The highlighted gray area represents the controls 
for the media, where pB42AD-T+pLexA-BD-p53 is the positive control and pB42AD-T+pLexA-BD-Lam 
is the negative control. Each interaction was measured five times from five different transformations. 
 
Ubx Isoform β-galactosidase units 
pLexA-UbxIbPro4 66.29 ± 26.69 
pLexA-UbxIbN216 1.89 ± 0.04 
pLexA-UbxIb103-216 39.49 ± 6.77 
pLexA-UbxIVaPro4 24.89 ± 7.68 
pB42AD-T+pLexA-BD-p53 
 
171.29 ± 45.52 
pB42AD-T+pLexA-BD-Lam 
 
0.67 ± 0.30 
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FIGURE 2. Overall results from the β-galactosidase liquid assays. This chart relays the average of the 
β-galactosidase liquid assays for various binding partners, as seen previously in Table 1. The first four 
bars to the left of the graph, in blue, denote the various Ubx isoforms that were tested using CBP80. The 
two red bars on the right of the graph represent controls for the media provided when the media was 
purchased. 
 
 
The Ubx isoform pLexA-UbxIbPro4 had the strongest interaction with 66.29 ± 26.69 β-
galactosidase units. With 1.89 ± 0.04 β-galactosidase units the Ubx isoform pLexA-
UbxIbN216 had the weakest interaction with CBP80, a detectable level of interactions 
barely above background levels. The β-galactosidase units, and therefore binding 
interactions, markedly diminished when the region N-term to the 216th amino acid was 
removed. These results followed our expectations, and reinforced that the lack of 
intrinsic disorder does affect Ubx binding CPB80. The pLexA-UbxIbN216 isoform is 
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utilized to test the role of the intrinsic disorder within the region N-term to the 216th 
amino acid, and found this region contributes to binding. Since pLexA-UbxIbN216 does 
remove a large portion of the disorder within Ubx, it also removes a segment of structure 
at the N-terminus. This would consequently skew our findings; therefore we used 
pLexA-UbxIb103-216 to only remove the large portion of the disorder, but maintain the 
upstream structured region.  
 
The other two isoforms revealed that the second unstructured region also play a role in 
protein-protein interactions. The isoform pLexA-UbxIb103-216 had 39.49 ± 6.77 β-
galactosidase units, an increase in β-galactosidase units compared to the interactions 
made by pLexA-UbxIbN216. The isoform pLexA-UbxIVaPro4 had 24.89 ± 7.68 β-
galactosidase units, also indicating an increase in binding interactions compared to 
pLexA-UbxIbN216. When comparing the two interaction levels of pLexA-UbxIb103-
216 and pLexA-UbxIVaPro4, the results do not concur with our hypothesis. Because 
pLexA-UbxIb103-216 has a larger portion of intrinsic disorder removed, one would 
think that pLexA-UbxIVaPro4 should have slightly more β-galactosidase units than 
pLexA-UbxIb103-216. There are three possible explanations for this result. First, the 
structured regions N-term to the 103rd amino acid could have an influence on binding, 
thus the minimal decrease in β-galactosidase units when the amino acids 103-216 were 
removed.  Second, there are small regions of disorder of less than 20 amino acids N-term 
to the 103rd amino acid, which could also affect binding, and lessen the severity of 
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loosing the major region of disorder. Third, these results can be due to residual 
transcription activation by Ubx, since the proline mutation is absent. 
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CHAPTER IV 
SUMMARY AND DISCUSSION 
 
Summary 
When examining the effect microexons have on binding, by comparing pLexA-
UbxIbPro4 and pLexA-UbxIVaPro4, it is apparent that the microexons do contribute to 
CBP80 binding. The Ubx N216 truncation shows almost no interaction between Ubx and 
CBP80, deeming this region a major determinant of CBP80 binding. Looking at the two 
interaction levels of pLexA-UbxIb103-216 and pLexA-UbxIVaPro4, it seems as though 
the microexons may have a larger effect on binding interaction than the large portion of 
disorder from amino acids 103-216. Comparing pLexA-UbxIbN216 and pLexA-
UbxIb103-216 indicates that either the mostly structured region N-term to the 103rd 
amino acid also impacts binding or pLexA-UbxIb103-216 has higher baseline levels of 
auto-activation. 
 
Discussion 
Further examinations of the microexons are to be conducted to evaluate the effect of 
each region on Ubx binding its partner protein. The varying levels of protein-protein 
interactions as the result of splicing could be an advantage in vivo. The use of 
microexons for protein interactions could allow a developing animal to regulate protein 
interactions through stage and tissue specific alternative splicing (10).  
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The graduate student working on the same project, Hao-Ching Hsiao, has recently 
carried out experiments using Ubx isoforms and multiple binding partners that were not 
discussed in this paper. The patterns observed for CBP80 interactions are also observed 
for the other partners as well, with the only exception being that the isoform pLexA-
UbxIb103-216 has more β-galactosidase units than pLexA-UbxIVaPro4. The trends are 
similar for other partners with an alpha-alpha super helix fold and partners with different 
folds. This reinforces the thought that the intrinsic disorder selects partners by topology.  
 
The hypothesis that the intrinsic disorder would prefer a protein partner with grooves or 
a canyon-like shape is still being tested. The canyon-like shape would surround the 
intrinsically disordered region, increasing number of molecular interactions with the 
binding partners. This increase in interactions would likely lead to a higher expression of 
β-galactosidase units when comparing to a partner that has one tangent interaction 
between the disordered region of Ubx and its partner. This presumption concurs with the 
initial results of testing done in Indiana by A. Keith Dunker that suggest that the partners 
with canyon-like folds bind more intrinsically disordered proteins than partners without 
this canyon like fold. 
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